MSB 3.21% $1.13 mesoblast limited

Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain, page-150

  1. 3,369 Posts.
    lightbulb Created with Sketch. 283
    those acknowledged experts didn't give the FDA what the FDA wanted for aGvHD approval..... so......
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.